Bioservo Technologies announces the start of the clinical study for Carbonhand® within the framework of the Horizon 2020 iHand project
Bioservo Technologies AB (publ) (Nasdaq First North: BIOS) has engaged Roessingh Research and Development in the Netherlands to coordinate a clinical trial studying the rehabilitation effects of Carbonhand on patients with an impaired hand function, which is part of the iHand project.Supporting this, a total of seven Dutch rehabilitation centres are collaborating: UMCG Centre for Rehabilitation (Groningen), Isala (Zwolle), Reade Rehabilitation / Rheumatology (Amsterdam), Rijndam Rehabilitation (Rotterdam), De Hoogstraat (Utrecht), Sint Maartenskliniek (Nijmegen) and Roessingh, Centre for